Melanoma Cancer is a killer, whose incidence is growing worldwide. The global costs of diagnosis and treatment are measured in $billions annually. Application of the nomela device will reduce costs dramatically, generating significant profits.
Sign up now to gain full access to pitches and investor profiles
You have passed the test and you may continue your with your investment.